University of California, San Francisco | HDFCCC - Hematopoietic malignancies

San Francisco, California 94158

1 studies enrolling now · 5 studies all time

What they study most

Advanced Breast Cancer, Advanced Gastric Cancer, Appendiceal Adenocarcinoma, Bladder Cancer, Breast Neoplasms, Carcinoma, Non-Small Cell Lung, Cervical Cancer, Classical Hodgkin Lymphoma, Colorectal Neoplasms, Cutaneous Melanoma, Diffuse Large B-cell Lymphoma, Endometrial Neoplasms

Studies at this site

• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 — Running, not enrolling
• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors — Running, not enrolling
• A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer — Stopped early
• A Study of SGN-STNV in Advanced Solid Tumors — Stopped early